Moffitt logo

Articles related to Treatment

research-leukemia-640.jpg

Moffitt’s Top Research Developments of 2017: New Hope for Aggressive Leukemia

Patients with certain fast-progressing and deadly types of acute myeloid leukemia (AML) saw the first new drug for their disease in more than 40 years approved by the FDA. Read More


research-adaptive-therapy-640.jpg

Moffitt’s Top Research Developments of 2017: Less is More: Adaptive Therapy

The fourth one on the list of Moffitt research developments for 2017 involves rethinking drug resistance with a strategy called adaptive therapy that links the frequency, dosage and type of chemo to the tumor’s response. Read More


research-cancer-fighting-640.jpg

Moffitt’s Top Research Developments of 2017: New Targets for Existing Cancer-Fighting Drugs

The third item on the list of Moffitt research developments for 2017 involves new targets for existing cancer-fighting drugs. Read More


Metastatic-breast-cancer.jpg

Behind the Science: 'Super Molecules’ Show Promise in Prevention of Metastatic Breast Cancer

What if a drug commonly used to protect bones from osteoporosis could be altered to keep out breast cancer cells? That’s the goal one Moffitt researcher is pursuing through the creation of "Smart Molecules." Read More


Life-After-Breast-Cancer.jpg

Five Questions About Life After Breast Cancer With Dr. Hoover

Dr. Susan Hoover, a surgical oncologist in the Breast Oncology Program at Moffitt Cancer Center, answers five questions about life after breast cancer. Read More


Radiation-Oncologist-vs-Radiologist.jpg

Radiation Oncologist vs. Radiologist

If you’re wondering what the difference is between a radiation oncologist and a radiologist, you’re not alone. Read More


COMMUNITY OF COURAGE

STORIES TO INSPIRE YOU ON YOUR JOURNEY THROUGH CANCER